Cellebrite DI: I see the 30% drop as a buying opportunity

JPMorgan sees a price potential of currently over 40%
The P/S ratio is trading below 5 after the setback
Andreas Zehetner
A. Zehetner
Reading Time: 2 minutes

Cellebrite DI (CLBT, i) was excessively punished on August 13 due to the second-quarter results and the unexpected CEO change, with a temporary drop of over 30%. On one hand, there are longer sales cycles and lower monetization progress with Inseyets product upgrades, and on the other hand, Shiven Ramji has been appointed as the new CEO effective immediately, who seems to be the right person with extensive experience in software companies. The core story remains unchanged. As a specialist in digital forensics, Cellebrite supports 7,000 customers...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In